Search Results 381-390 of 14967 for alt

1. A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab - Mayo Clinic

   alanine aminotransferase (ALT, SGPT) ≤ 3.5 x upper limit of normal (ULN);; aspartate aminotransferase (AST, SGOT) ≤ 2.5 x ULN;; total bilirubin ≤ 1.5 x ULN ...

2. Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy) - Mayo Clinic

   Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤5 × ULN. Have adequate renal function as evidenced by: Serum creatinine <1.5 × ULN; OR ...

3. A Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors - Mayo Clinic

   Alanine aminotransferase (ALT) and (aspartate aminotransferase) AST ≤ 3x institutional upper limit of normal (ULN); Total bilirubin ≤ 1.5x institutional ...

4. A Study to Assess the Effectiveness of Osimertinib Plus Savolitinib in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Progressed Following Osimertinib Treatment (SAVANNAH Study) Following Prior Osimertinib - Mayo Clinic

   Participation eligibility · Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 x the upper limit of normal (ULN) with total bilirubin ( ...

5. Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients with Newly Diagnosed Ependymoma - Mayo Clinic

   AST or ALT < 3 times ULN; Adequate cardiac function defined as 1 of the following: Shortening fraction ≥ 27% by ECHO; Ejection fraction ≥ 50% by gated ...

6. A Study to Evaluate Triapine Combined with Lutetium Lu 177 Dotatate for Gastroenteropancreatic Neuroendocrine Tumors - Mayo Clinic

   AST(SGOT)/ALT(SGPT) ≤ 3 × institutional ULN;; glomerular filtration rate (GFR) ≥ 50 mL/min using Cockroft-Gault method;; hemoglobin ≥ 8.0 g/dL. Human ...

7. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 x ULN. Acute or chronic liver disease. Known hypersensitivity to inactive ingredients ...

8. Bemarituzumab plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab Alone - Mayo Clinic

   - Aspartate aminotransaminase (AST) and Alanine aminotransaminase (ALT) <3 x upper limit of normal (ULN) (or < 5 x ULN if liver involvement) - Total ...

9. PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS - Mayo Clinic

   - Alanine aminotransferase (AST) and aspartate aminotransferase (ALT) < 3.0 x ULN. - Ejection fraction measured by echocardiogram (ECHO) or multi gated ...

10. A Study of the Effectiveness and Safety of Targeted Delivery of Auto CD34+ Stem Cells into Heart Muscle for Improving Exercise Capacity in People with Angina Resistant to Treatment - Mayo Clinic

    Hepatic dysfunction as evidenced by elevated AST or ALT levels > 2.5 x ULN; Any previous transplant requiring immunosuppression; Disease state requiring ...